Palatin Technologies (PTN) Raw Materials (2021)
Palatin Technologies' (PTN) quarterly Raw Materials came in at $526000.0 in Q2 2021.
Analysis
Palatin Technologies (PTN) Raw Materials (2021) Analysis & Trends
Palatin Technologies (PTN) has reported Raw Materials for 1 consecutive years, with $526000.0 the latest figure, recorded in Q2 2021.
- For the quarter ending Q2 2021, Raw Materials changed N/A year-over-year to $526000.0; the trailing twelve-month figure through Jun 2021 stood at $526000.0 (changed N/A YoY), and the FY2021 full-year result was $526000.0, changed N/A from the prior year.
- Raw Materials held at $526000.0 in Q2 2021 per PTN's latest filing.
- Across five years, Raw Materials topped out at $526000.0 in Q2 2021 and bottomed at $526000.0 in Q2 2021.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn |
| 10 | Palatin Technologies | 46.98 Mn | 46.98 Mn | - |